Closed Surgical Wound Drainage Market Forecast till 2030
Cardinal Health (US), Zimmer Biomet (US), Axiom Medical, Inc. (US), Angiplast Pvt. Ltd. (India), Polymedicure (India), Becton, Dickinson, and Company (US), Braun SE (Germany), StayGuard (US), Medline Industries, Inc. (US), and VariVac International Medical Research Pty Ltd. (Australia), Ingelheim (Ingelheim am Rhein, Germany), Vetoquinol (Lure, France), Ceva Animal Health, LLC (Libourne, France), Chanelle Pharma (Galway, Ireland), Elanco (Indiana, US), SOMAVAC Medical Solutions, Inc. (US).
Companies Mentioned
Cardinal Health (US) Zimmer Biomet (US) Axiom Medical Inc. (US) Angiplast Pvt. Ltd. (India) Polymedicure (India) Becton Dickinson and Company (US) Braun SE (Germany) StayGuard (US) Medline Industries Inc. (US) and VariVac International Medical Research Pty Ltd. (Australia) Ingelheim (Ingelheim am Rhein Germany) Vetoquinol (Lure France) Ceva Animal Health LLC (Libourne France) Chanelle Pharma (Galway Ireland) Elanco (Indiana US) SOMAVAC Medical Solutions Inc. (US).
1 Executive Summary
1.1 Overview
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.3 Research Objective
2.4 Market Structure
2.5 Assumptions & Limitations
3 Research Methodology
3.1 Data Mining
3.2 Secondary Research
3.3 Primary Research
3.4 Breakdown Of Primary Respondents
3.5 Forecasting Techniques
3.6 Research Methodology For Market Size Estimation
3.6.1 Bottom-up Approach
3.6.2 Top-down Approach
3.7 Data Triangulation
3.8 Validation
4 Market Dynamics
4.1 Overview
4.2 Drivers
4.2.1 Increasing Incidence Of Chronic Wounds And Surgical Site Infections
4.2.2 Rising Prevalence Of Chronic Diseases
4.2.3 Rising Awareness About The Benefits Of Closed Surgical Wound Drainage And Technological Advancements
4.3 Restraints
4.3.1 Increasing Concerns Over Side Effects
4.3.2 Rise In The Number Of Minimally Invasive Surgeries
4.4 Opportunities
4.4.1 Growing Aging Population
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D & Designing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-sales Monitoring
5.2 Porter's Five Forces Model
5.2.1 Threat Of New Entrants
5.2.2 Bargaining Power Of Suppliers
5.2.3 Threat Of Substitutes
5.2.4 Bargaining Power Of Buyers
5.2.5 Intensity Of Rivalry
5.3 Impact Of Covid-19 On The Global Closed Surgical Wound Drainage Market
5.3.1 Impact On Market Growth
5.3.2 Demand Supply Analysis
5.3.3 Impact On Key Players
5.4 Reimbursement Scenario For Closed Surgical Wound Drainage
5.4.1 Reimbursement Scenario By Country
6 Global Closed Surgical Wound Drainage Market, By Product
6.1 Overview
6.2 Closed Surgical Drainage Systems
6.3 Accessories
7 Global Closed Surgical Wound Drainage Market, By Type
7.1 Overview
7.2 Active Drains
7.3 Passive Drains
8 Global Closed Surgical Wound Drainage Market, By Age Group
8.1 Overview
8.2 Adult
8.3 Paediatric
9 Global Closed Surgical Wound Drainage Market, By Application
9.1 Overview
9.2 General Surgery
9.3 Orthopedics Surgery
9.4 Cardiac & Thoracic Surgery
9.5 Obstetric/Gynecological Surgery
9.6 Others
10 Global Closed Surgical Wound Drainage Market, By End User
10.1 Overview
10.2 Hospitals & Clinics
10.3 Ambulatory Surgical Centers
10.4 Others
11 Global Closed Surgical Wound Drainage Market, By Region
11.1 Overview
11.2 North America
11.2.1 Us
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 Uk
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest Of Europe
11.4 Asia-pacific
11.4.1 China
11.4.2 India
11.4.3 Japan
11.4.4 South Korea
11.4.5 Australia
11.4.6 Rest Of Asia-pacific
11.5 Rest Of The World
11.5.1 Africa
11.5.2 Latin America
11.5.3 Middle East
12 Competitive Landscape
12.1 Overview
12.2 Competitive Benchmarking
12.3 Major Growth Strategy In The Global Closed Surgical Wound Drainage Market
12.4 The Leading Player In Terms Of The Number Of Developments In The Global Closed Surgical Wound Drainage Market
12.5 Financial Matrix
12.5.1 Sales (Usd Million),
12.5.2 Research & Development Expenditure (Usd Million),
13 Company Profiles
13.1 Cardinal Health
13.1.1 Company Overview
13.1.2 Financial Overview
13.1.3 Products Offered
13.1.4 Key Developments
13.1.5 Swot Analysis
13.1.6 Key Strategies
13.2 Zimmer Biomet
13.2.1 Company Overview
13.2.2 Financial Overview
13.2.3 Products Offered
13.2.4 Key Developments
13.2.5 Swot Analysis
13.2.6 Key Strategies
13.3 Axiom Medical, Inc
13.3.1 Company Overviews
13.3.2 Financial Overview
13.3.3 Products Offered
13.3.4 Key Developments
13.3.5 Key Strategies
13.4 Angiplast Pvt. Ltd
13.4.1 Company Overview
13.4.2 Financial Overview
13.4.3 Products Offered
13.4.4 Key Developments
13.4.5 Key Strategies
13.5 Polymedicure
13.5.1 Company Overview
13.5.2 Financial Overview
13.5.3 Products Offered
13.5.4 Key Developments
13.5.5 Key Strategies
13.6 Becton, Dickinson And Company
13.6.1 Company Overview
13.6.2 Financial Overview
13.6.3 Products Offered
13.6.4 Key Developments
13.6.5 Swot Analysis
13.6.6 Key Strategies
13.7 B. Braun Se
13.7.1 Company Overview
13.7.2 Financial Overview
13.7.3 Products Offered
13.7.4 Key Developments
13.7.5 Swot Analysis
13.7.6 Key Strategies
13.8 Stayguard
13.8.1 Company Overview
13.8.2 Products Offered
13.8.3 Key Developments
13.8.4 Key Strategies
13.9 Medline Industries, Inc
13.9.1 Company Overview
13.9.2 Financial Overview
13.9.3 Products Offered
13.9.4 Key Developments
13.9.5 Swot Analysis
13.9.6 Key Strategies
13.10 Varivac International Medical Research Pty Ltd
13.10.1 Company Overview
13.10.2 Financial Overview
13.10.3 Products Offered
13.10.4 Key Developments
13.10.5 Key Strategies
14 Appendix
14.1 References
14.2 Related Reports
List Of Tables
Table 1 List Of Assumptions & Limitations
Table 2 Primary Interviews And Information Gathering Process